Followers | 16 |
Posts | 4409 |
Boards Moderated | 0 |
Alias Born | 04/13/2016 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 11, 2023 1:55:28 PM
Different kinds of testing or procedures might be needed for these different applications. I don’t know.
The easiest applications for DS or MS are external. I knew a child born with Epidermolysis bullosa. He had to have bandages on his skin and it hurt terribly to have to peel them off every day and replace them. A spider silk bandage could have reduced the frequency of changes to perhaps every 4 or 5 days. That would have been a blessing for this poor kid. I’m guessing that bandage makers are the first to ask for DS or MS.
Only about a year ago was KBLB able to ship fibers to a few more medical companies. I’m guessing this might have included a few who specialize in internal applications. Each company will do their own testing on the fibers. The test for calcification is important in some applications, but not others, for example.
When research papers appear, they will include methods of clearing sericin and testing for clearance. How many research articles have mentioned KBLB? Pretty sure none of them. That means research is just getting started. But if a company is going to spend five million bucks to develop a new heart valve, they probably want to lock KBLB in as a sole supplier. That will be done thru a joint venture. No medical company wants to be in a situation where KBLB is shipping material to seven or eight of their competitors, all of whom are working to develop heart valves. That is the reason for a joint venture.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM